In Vitro Diagnostics (IVD) is an important segment in the global healthcare industry. The diagnostic tests that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home. Technological advancements, better diagnostic tools, and improved treatment monitoring, and increased availability of over-the-counter tests are mainly driving the global in vitro diagnostics market. In vitro diagnostics provide valuable information regarding the physiological and/or pathological state of the body and therefore are essential to make well-informed medical decisions. In vitro diagnostic products are those reagents, instruments, and systems intended for use in diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. Such products are intended for use in the collection, preparation, and examination of specimens taken from the human body.
The global in vitro diagnostics market report estimates the market size (Revenue US$ million – 2014 to 2021) and composition of this market and also forecasts growth trends (CAGR% – 2017 to 2021).
The global in vitro diagnostics market is segmented by clinical applications (blood testing, clinical chemistry, diabetes testing, immunoassay, molecular diagnostics).
The global in vitro diagnostics market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global in vitro diagnostics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global in vitro diagnostics market and included in this report are Abbott Laboratories Inc., Alere Inc., Bayer AG, Becton Dickinson and Company, Biomerieux SA, Beckman Coulter Inc., Danaher Corporation, Gen-Probe Incorporated, Johnson and Johnson, Life Technologies Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare (a division of Siemens AG) and Thermo Fisher Scientific Corporation.